Cancer therapy: it was by persisting that the Greeks took Troy

A rather pessimistic wind is blowing over cancer chemotherapy, while a not very objective enthusiasm for second generation immunotherapy is raising its head. As the natural father of the first allogeneic bone marrow graft, of lymphocyte transfusions and of active immunotherapy, my duty is to show that chemotherapy is doing fine, and that the neo-immunotherapists would do well do draw some lesions from retrospective studies in their field, which might guide their approach towards efficient cancer (and AIDS) therapy.